Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Haleon PLC Sponsored ADR (HLN) vs Viatris Inc. (VTRS)

Haleon PLC Sponsored ADR and Viatris Inc. are both Drug Manufacturers Specialty & Generic companies. Haleon PLC Sponsored ADR is the larger, with a market value of $40.3B against $20.0B — 2.0× the size. Viatris Inc. has negative trailing earnings, so its P/E is not meaningful; Haleon PLC Sponsored ADR trades at 20.6×. Haleon PLC Sponsored ADR has the higher net margin (13.8% vs −2.79%) and the higher return on invested capital (0.00% vs −0.20%). Both pay a dividend; Viatris Inc. yields more (4.15% vs 1.70%). Across the 21 metrics below, Haleon PLC Sponsored ADR leads on 13 and Viatris Inc. on 8.

Valuation

Metric HLN VTRS Drug Manufacturers Specialty & Generic median
P/E 20.64 n/m 20.14
P/S 2.35 1.41 2.25
P/B 1.93 1.45 1.90
Price to free cash flow 9.36 10.97 16.54
EV/EBITDA 12.36 12.22 12.29
EV/Sales 2.90 2.25 2.56
Earnings yield 4.84% (2.02%) (2.99%)
Free cash flow yield 10.68% 9.11% 0.00%

Profitability

Metric HLN VTRS Drug Manufacturers Specialty & Generic median
Gross margin 62.22% 34.83% 53.94%
Operating margin 17.93% (0.59%) 0.00%
Net margin 13.79% (2.79%) 0.00%
Free cash flow margin 0.00% 12.83% 0.00%
Return on equity 0.00% (2.75%) (0.40%)
Return on assets 0.00% (1.12%) (3.32%)
Return on invested capital 0.00% (0.20%) 0.00%

Growth

Metric HLN VTRS Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 4.40% 10.01%
EPS growth (last fiscal year) 22.50% (466.04%) —
Revenue growth, 5-year CAGR 1.43% 3.66% 6.74%
Net income growth, 5-year CAGR 6.98% 0.00% 0.00%

Health

Metric HLN VTRS Drug Manufacturers Specialty & Generic median
Debt to equity 0.50 0.94 0.05
Current ratio 0.69 1.58 2.31
Net debt to EBITDA 2.63 4.92 0.85

Dividend

Metric HLN VTRS Drug Manufacturers Specialty & Generic median
Dividend yield 1.70% 4.15% 1.70%
Payout ratio — 0.31 0.00

Size

Metric HLN VTRS Drug Manufacturers Specialty & Generic median
Market cap 40.28b 19.99b 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack